Skip to content

New Era of DIEP With Minimally Invasive Mastectomy

Shifting Strategic Approach in Breast Reconstruction Using Free DIEP Flap Along With The Paradigm Shifting of Mastectomy Technique

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06321549
Enrollment
278
Registered
2024-03-20
Start date
2022-10-03
Completion date
2023-10-02
Last updated
2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Reconstruction, Mastectomy; Lymphedema

Brief summary

The free deep inferior epigastric artery perforator (DIEP) flap is the gold standard in autologous breast reconstruction. Asian patients often present with a smaller body mass index with relatively insufficient tissue. To restore appropriate symmetry, a larger flap inset ratio must be transferred. Supercharging of the second vein or inclusion of bilateral pedicle is commonly required. Current paradigm shifts in mastectomy has also resulted in more minimally invasive surgeries (MIS) espousing smaller lateral incisions, leading to a significant change in available recipient vessels. This study aimed to demonstrate our experience in changing strategies of DIEP flaps following the evolution of mastectomy techniques. Between October 2008 and March 2022, retrospective data was gathered for 278 patients who underwent breast reconstruction surgery utilizing DIEP flaps by a single plastic surgeon. These patients were divided into two distinct groups based on their operation dates, with November 2018 marking a pivotal moment when the first MIS was introduced.

Interventions

OTHERThe reference point of minimally invasive mastectomy procedure conducted

November 2018 as a temporal reference point was predicated on the milestone of the medical center's inaugural minimally invasive mastectomy procedure conducted

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* All patients who underwent breast reconstruction procedures with DIEP flaps from October 2008 to March 2022. * Patients who have a minimum follow-up duration of six months post-reconstruction.

Exclusion criteria

* Patients who did not meet the six-month follow-up duration was excluded from the study.

Design outcomes

Primary

MeasureTime frame
Endoscopy mastectomyPost-operative day 0
Robotic mastectomyPost-operative day 0
IncisionPost-operative day 0
Usage of SIEVPost-operative day 0
Inclusion of bipediclePost-operative day 0
Location of recipient artery/veinPost-operative day 0
Recipient artery/vein selectionPost-operative day 0

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026